Scholar Rock (NASDAQ:SRRK) Stock Price Down 9%

Scholar Rock Holding Co. (NASDAQ:SRRK)’s stock price fell 9% during trading on Monday . The company traded as low as $7.94 and last traded at $7.94. 855,710 shares changed hands during trading, an increase of 5% from the average session volume of 814,371 shares. The stock had previously closed at $8.73.

Wall Street Analyst Weigh In

Several analysts have commented on the company. HC Wainwright reissued a “buy” rating and issued a $30.00 price objective on shares of Scholar Rock in a report on Tuesday, June 25th. Wedbush reiterated an “outperform” rating and set a $23.00 price objective on shares of Scholar Rock in a research note on Thursday, August 8th. Finally, BMO Capital Markets boosted their price target on Scholar Rock from $31.00 to $34.00 and gave the stock an “outperform” rating in a research report on Friday, August 9th. Six equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $26.43.

Scholar Rock Price Performance

The company has a fifty day moving average price of $8.90 and a two-hundred day moving average price of $10.92. The company has a quick ratio of 6.04, a current ratio of 6.04 and a debt-to-equity ratio of 0.36. The firm has a market capitalization of $638.03 million, a price-to-earnings ratio of -3.85 and a beta of 0.82.

Scholar Rock (NASDAQ:SRRK) last issued its earnings results on Thursday, August 8th. The company reported ($0.60) EPS for the quarter, topping the consensus estimate of ($0.61) by $0.01. During the same quarter in the previous year, the business earned ($0.47) EPS. On average, equities research analysts expect that Scholar Rock Holding Co. will post -2.39 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Charles Schwab Investment Management Inc. raised its position in Scholar Rock by 30.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 394,138 shares of the company’s stock valued at $7,410,000 after acquiring an additional 91,754 shares in the last quarter. Jane Street Group LLC increased its holdings in shares of Scholar Rock by 95.5% during the first quarter. Jane Street Group LLC now owns 244,318 shares of the company’s stock worth $4,339,000 after buying an additional 119,363 shares in the last quarter. Rafferty Asset Management LLC bought a new stake in Scholar Rock during the 4th quarter worth approximately $2,025,000. Kennedy Capital Management LLC acquired a new stake in Scholar Rock during the 1st quarter valued at $4,900,000. Finally, Vanguard Group Inc. boosted its stake in Scholar Rock by 4.0% in the first quarter. Vanguard Group Inc. now owns 2,969,534 shares of the company’s stock worth $52,739,000 after purchasing an additional 114,550 shares in the last quarter. 91.08% of the stock is currently owned by institutional investors.

Scholar Rock Company Profile

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.